Byung Jun Kim

Prof. Byung Jun Kim


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2020 in Archives of Craniofacial Surgery
Verified
Journal Article
Open access
PDF file
JHJu Long Hu
Ju Long Hu
HYHyokyung Yoo
Hyokyung Yoo
SKSung Tack Kwon
Sung Tack Kwon
SKSukwha Kim
Sukwha Kim
JCJee Hyeok Chung
Jee Hyeok Chung
BKByung Jun Kim
Byung Jun Kim
Background: Pilomatrixoma is a benign tumor that originates from the hair follicle matrix. It usually presents as a hard, slow growing, solitary mass that can be easily misdiagnosed as other skin masses. The aim of this study was to clinically analyze a case series of pilomatrixoma in pediatric patients from Korea. Methods: A total of 165 pediatric patients from 2011 to 2018 with a histological diagnosis of pilomatrixoma were included. A retrospective review was performed using the electronic medical records, including patient demographics, number and location of the mass, clinical and imaging presentation, and postoperative outcomes. Results: There were 61 male and 104 female patients with 152 solitary and 13 multiple pilomatrixomas. Among solitary pilomatrixomas, the lesion commonly occurred in the head and neck (84.2%), followed by upper limbs (11.2%), lower limbs (3.3%), and trunk (1.3%). The pilomatrixoma lesion presented as the following types based on our clinical classification: mass (56.02%), pigmentation (25.31%), mixed (12.65%), ulceration (4.82%), and keloid-like (1.2%). Ultrasonography showed a high positive predictive value (95.56%). There were no specific complications observed except for two cases of recurrence. Conclusion: Pilomatrixoma has various clinical feature presentations and commonly occurs in the head and neck. Ultrasonography is a helpful diagnostic tool. Surgical removal of the lesion is the main treatment method with a low recurrence rate.

2 December 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JCJun Ho Choi
Jun Ho Choi
KAKyung Chan Ahn
Kyung Chan Ahn
HCHak Chang
Hak Chang
KMKyung Won Minn
Kyung Won Minn
UJUng Sik Jin
Ung Sik Jin
BKByung Jun Kim
Byung Jun Kim
Objective. We describe specific surgical methods for angiosarcoma regarding extent of resection and reconstructive options and assess their effect on patients’ prognosis.Patients and Methods. We retrospectively examined 14 patients undergoing treatment for angiosarcoma of the scalp at our institute between January 2000 and June 2015. Surgical treatment comprised wide excision of the tumor and reconstruction using a free flap with skin graft. Kaplan-Meier survival analysis was used to assess the survival parameters. Univariate and multivariate analyses were performed to evaluate the association between risk factors and outcome parameters.Results. Mean patient age at diagnosis was 69 years, and the mean follow-up period was 17 months. The overall 5- and 2-year survival rates were 15% and 75%, respectively, whereas the 5- and 2-year disease-free survival rates were 7.7% and 38.7%, respectively. The mean survival duration was 32 months. Metastatic tumor dissemination to the lung or brain was closely associated with the major cause of death. Only a deep excision margin was significantly related to the recurrence rate.Conclusions. Cases of angiosarcoma had a poor prognosis despite the aggressive treatments. Sufficient resection margins are essential for controlling local recurrence. The effect of multidisciplinary approaches needs to be explored.

1 May 2018 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
BKByung Jun Kim
Byung Jun Kim
YPYinglan Piao
Yinglan Piao
MWMaierdanjiang Wufuer
Maierdanjiang Wufuer
WSWoo-Chan Son
Woo-Chan Son
TCTae Hyun Choi
Tae Hyun Choi

21 December 2021 in Dermatologic Surgery
Verified
Journal Article
Closed access
JKJi-Young Kim
Ji-Young Kim
JJJi Hui Jeon
Ji Hui Jeon
TCTae Hyun Choi
Tae Hyun Choi
BKByung Jun Kim
Byung Jun Kim
BACKGROUND: Although giant congenital melanocytic nevus (GCMN) is regarded as premalignant, the incidence and risk factors of malignant transformation are controversial. OBJECTIVE: This study aimed to share the authors’ surgical experience with GCMNs and provide data on their demographics, malignant transformation, and prognosis. METHODS: This single-center, consecutive study included 152 patients with GCMN who visited this center from March 2000 to February 2020. Their medical documentation was reviewed retrospectively, and the nevi were classified according to the size as follows: Group 1, 10 to 19.9 cm (n = 45); Group 2, 20 to 39.9 cm (n = 62); and Group 3, ≥40 cm (n = 45). RESULTS: Seven malignancies were found (4.6%; 4 melanomas, 2 rhabdomyosarcomas [RMS], and 1 malignant peripheral nerve sheath tumor [MPNST]). The risk increased according to the nevus size (2.2% in Group 1, 3.2% in Group 2, and 8.9% in Group 3) but the difference was not statistically significant (p = .3305). CONCLUSION: Malignant transformation from GCMN cannot be ignored. It can include transformation into melanoma, RMS, and MPNST. Early surgical resection and regular follow-up should be performed in patients with nevi ≥10 cm.

1 September 2021 in Archives of Hand and Microsurgery
Verified
Journal Article
Open access
PDF file
HYHyokyung Yoo
Hyokyung Yoo
BKByung Jun Kim
Byung Jun Kim
Since the late 19th century, microsurgery has achieved many miracles in history of surgery. With the development of microsurgical instruments and techniques, especially the first operating microscope invented by Carl Zeiss in 1953, the limitations steadily decreased and finally reached a limitless level of today’s supermicrosurgery. The chronological history of microsurgery can be divided into four periods: the beginning period of the late 19th to early 20th century when the essential microsurgical tools and concepts were established; the successful replantation of amputated extremities in the 1960s; the development of various kinds of flap in the 1980s; and the fully-matured period of today. This article reviews the milestones in the history of microsurgery, evaluates the recent advances, as well as microsurgery in Korea.

1 March 2020 in Cancer Letters
Verified
Journal Article
Open access
SLSo-Young Lee
So-Young Lee
SYSoo-Bin Yang
Soo-Bin Yang
YCYu-min Choi
Yu-min Choi
SOSong-Ji Oh
Song-Ji Oh
BKByung Jun Kim
Byung Jun Kim
Bum-Joon KimBum-Joon Kim
Bum-Joon Kim
A therapeutic strategy capable of skewing toward a Th1-type immune response is crucial for cancer treatment. Recently, we reported Mycobacterium paragordonae (Mpg) as a potential live vaccine for mycobacterium infections. In this study, we explored the immunotherapeutic potential of heat-killed Mpg (HK-Mpg) in a mouse tumor xenograft model and elucidated its underlying antitumor mechanisms. MC38 cells derived from murine colon adenocarcinoma were implanted by subcutaneously injecting mice. The anticancer effects of HK-Mpg therapy were compared with HK-M. bovis BCG, an effective adjuvant for cancer immunotherapy. HK-Mpg treatment enhanced tumor reduction and mouse survival. Furthermore, HK-Mpg treatment synergistically enhanced the anticancer therapeutic effect of cisplatin. In addition, HK-Mpg enhanced inflammatory cytokine production and recruitment of immune cell into tumor-infiltrating sites and splenocytes in vaccinated mice. Our mechanistic study demonstrates that HK-Mpg therapy elicits a strong antitumor immune response in mice, mainly through natural killer cell-mediated oncolytic activity via the activation of dendritic cells (DCs) and by enhancing inflammatory cytokines production such as IL-12 from DC. Hence, HK-Mpg can be a potential immunotherapy adjuvant, enhancing the effect of cancer chemotherapy.